Blood Res.  2014 Sep;49(3):205-207. 10.5045/br.2014.49.3.205.

Second case of postpartum acquired hemophilia A in a Korean female

Affiliations
  • 1Department of Pediatrics, Kyungpook National University Hospital and Kyungpook National University School of Medicine, Daegu, Korea. kslee@knu.ac.kr
  • 2Hanyoung Children's Hospital, Daegu, Korea.
  • 3Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.

Abstract

No abstract available.


MeSH Terms

Female
Hemophilia A*
Humans
Postpartum Period*

Reference

1. Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007; 109:1870–1877. PMID: 17047148.
Article
2. Yee TT, Taher A, Pasi KJ, Lee CA. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol. 2000; 22:275–278. PMID: 11122268.
Article
3. Huth-Kuhne A, Baudo F, Collins P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009; 94:566–575. PMID: 19336751.
Article
4. Tengborn L, Baudo F, Huth-Kuhne A, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG. 2012; 119:1529–1537. PMID: 22901076.
Article
5. Lee JH, Kim DH, Yoo K, Choi Y, Kim SH, Kim HJ. The first case of postpartum acquired hemophilia A in Korea. J Korean Med Sci. 2011; 26:1247–1249. PMID: 21935285.
Article
6. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia. 2004; 10:169–173. PMID: 14962206.
Article
7. Sumner MJ, Geldziler BD, Pedersen M, Seremetis S. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia. 2007; 13:451–461. PMID: 17880429.
Article
8. Aledort LM. Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues. Haemophilia. 2008; 14:39–43. PMID: 17961169.
Article
9. Abshire T, Kenet G. Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors. Haemophilia. 2008; 14:898–902. PMID: 18684126.
Article
10. Lee YS, Ng HJ. Mycophenolate in the remission induction of a patient with acquired haemophilia A. Haemophilia. 2010; 16:180–182. PMID: 19780847.
Article
11. Petrovic M, Derom E, Baele G. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies. Haematologica. 2000; 85:895–896. PMID: 10942956.
12. Hauser I, Schneider B, Lechner K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost. 1995; 73:1–5. PMID: 7740477.
13. Coller BS, Hultin MB, Hoyer LW, et al. Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood. 1981; 58:619–624. PMID: 6789845.
Article
14. Baudo F, de Cataldo F. Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. BJOG. 2003; 110:311–314. PMID: 12628274.
Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr